Time to Stop Using Ineffective Covid-19 Drugs

Affiliations

¹ From the Centre for the AIDS Programme of Research in South Africa, Durban (S.S.A.K., N.D.); and the Department of Epidemiology, Mailman School of Public Health, Columbia University, New York (S.S.A.K.).

Editorial

Salim S Abdool Karim et al. N Engl J Med. 2022.

. 2022 Aug 18;387(7):654-655.

doi: 10.1056/NEJMe2209017.

¹ From the Centre for the AIDS Programme of Research in South Africa, Durban (S.S.A.K., N.D.); and the Department of Epidemiology, Mailman School of Public Health, Columbia University, New York (S.S.A.K.).

No abstract available

Comment on

Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19.
Bramante CT, Huling JD, Tignanelli CJ, Buse JB, Liebovitz DM, Nicklas JM, Cohen K, Puskarich MA, Belani HK, Proper JL, Siegel LK, Klatt NR, Odde DJ, Luke DG, Anderson B, Karger AB, Ingraham NE, Hartman KM, Rao V, Hagen AA, Patel B, Fenno SL, Avula N, Reddy NV, Erickson SM, Lindberg S, Fricton R, Lee S, Zaman A, Saveraid HG, Tordsen WJ, Pullen MF, Biros M, Sherwood NE, Thompson JL, Boulware DR, Murray TA; COVID-OUT Trial Team. Bramante CT, et al. N Engl J Med. 2022 Aug 18;387(7):599-610. doi: 10.1056/NEJMoa2201662. N Engl J Med. 2022. PMID: 36070710 Free PMC article. Clinical Trial.